PREGNANCY MULTIVITAMIN TABLET

Country: Kanada

Tungumál: enska

Heimild: Health Canada

Virkt innihaldsefni:

BETA-CAROTENE; VITAMIN B1 (THIAMINE MONONITRATE); VITAMIN B2 (RIBOFLAVIN); NICOTINAMIDE; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE); VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE); ASCORBIC ACID (ASCORBIC ACID); VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE); COPPER (COPPER GLUCONATE); IODINE (POTASSIUM IODIDE); IRON (FERROUS FUMARATE); MAGNESIUM (MAGNESIUM OXIDE); ZINC (ZINC OXIDE); FOLIC ACID; VITAMIN B12 (CYANOCOBALAMIN); VITAMIN D3 (CHOLECALCIFEROL); CALCIUM (CALCIUM CARBONATE)

Fáanlegur frá:

JAMP PHARMA CORPORATION

ATC númer:

B03AE04

INN (Alþjóðlegt nafn):

IRON, MULTIVITAMINS AND MINERALS

Skammtar:

1.6MG; 3MG; 3.4MG; 20MG; 5MG; 10MG; 120MG; 13.8MG; 2MG; 0.15MG; 35MG; 50MG; 15MG; 1.1MG; 12MCG; 600UNIT; 300MG

Lyfjaform:

TABLET

Samsetning:

BETA-CAROTENE 1.6MG; VITAMIN B1 (THIAMINE MONONITRATE) 3MG; VITAMIN B2 (RIBOFLAVIN) 3.4MG; NICOTINAMIDE 20MG; D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE) 5MG; VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10MG; ASCORBIC ACID (ASCORBIC ACID) 120MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8MG; COPPER (COPPER GLUCONATE) 2MG; IODINE (POTASSIUM IODIDE) 0.15MG; IRON (FERROUS FUMARATE) 35MG; MAGNESIUM (MAGNESIUM OXIDE) 50MG; ZINC (ZINC OXIDE) 15MG; FOLIC ACID 1.1MG; VITAMIN B12 (CYANOCOBALAMIN) 12MCG; VITAMIN D3 (CHOLECALCIFEROL) 600UNIT; CALCIUM (CALCIUM CARBONATE) 300MG

Stjórnsýsluleið:

ORAL

Einingar í pakka:

15G/50G

Gerð lyfseðils:

Prescription

Vörulýsing:

Active ingredient group (AIG) number: 1747661005; AHFS:

Leyfisstaða:

APPROVED

Leyfisdagur:

2023-02-22

Vara einkenni

_ Pregnancy Multivitamin Product Monograph_
_ Page 1 of 30_
PRODUCT MONOGRAPH
PR
PREGNANCY MULTIVITAMIN
Vitamin-Mineral Supplement Tablets for Prenatal/Postpartum Use
Oral, Blue Tablet (evening) contains 1.1 mg of Folic Acid
Multivitamins and other Minerals Including Combinations
JAMP Pharma Corporation
1310 rue Nobel
Boucherville, Quebec
J4B 5H3, Canada
Control No.: 252149
Date of Revision:
February 22, 2023
_ Pregnancy Multivitamin Product Monograph_
_ Page 2 of 30_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
...............................................................................................................
3
INDICATIONS AND CLINICAL USE
....................................................................................................................
4
CONTRAINDICATIONS
.........................................................................................................................................
4
WARNINGS AND PRECAUTIONS
........................................................................................................................
4
ADVERSE REACTIONS
..........................................................................................................................................
6
DRUG INTERACTIONS
........................................................................................................................................
10
DOSAGE AND ADMINISTRATION
....................................................................................................................
15
OVERDOSAGE
......................................................................................................................................................
16
ACTION AND CLINICAL PHARMACOLOGY
...................................................................................................
17
STORAGE AND STABILITY
...........................................................................